Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury-Reference-Cited by-同舟云学术

Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug‐Induced Liver Injury

Published:2019-06-06 Issue:8 Volume:3 Page:1032-1035
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Bonkovsky Herbert L.¹^ORCID,Severson Tyler¹,Nicoletti Paola²³,Barnhart Huiman⁴,Serrano Jose⁵,Chalasani Naga⁶,Fontana Robert J.⁷,Watkins Paul B.⁸,Navarro Victor⁹,Stolz Andrew¹⁰,Daly Ann K.¹¹,Aithal Guruparasad P.¹²,Odin Joseph²,

Affiliation:

1. Department of Medicine, Gastroenterology and Hepatology Section Wake Forest University School of Medicine Winston‐Salem NC

2. Icahn School of Medicine at Mount Sinai Medical Center New York NY

3. Sema4 Stamford CT

4. Duke Clinical Research Institute Durham NC

5. National Institute of Diabetes and Digestive and Kidney Diseases Bethesda MD

6. Division of Gastroenterology Indiana University School of Medicine Indianapolis IN

7. Division of Gastroenterology University of Michigan School of Medicine Ann Arbor MI

8. Departments of Pharmacology and Medicine University of North Carolina School of Medicine Chapel Hill NC

9. Department of Medicine Einstein Medical Center Philadelphia PA

10. Division of Gastroenterology and Hepatology University of Southern California School of Medicine Los Angeles CA

11. Newcastle University Newcastle‐upon‐Tyne United Kingdom

12. National Institute for Health Research, Nottingham Biomedical Research Centre Nottingham University Hospitals National Health Service Trust and the University of Nottingham Nottingham United Kingdom

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1382

Reference5 articles.

1. Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits

2. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review

3. Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles

4. Drug-Induced Liver Injury

5. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review;Exploration of Digestive Diseases;2023-12-27

2. Novel biomarkers for drug-induced liver injury;Clinical Toxicology;2023-08-03

3. Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia;JAMA Network Open;2022-12-29

4. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury;Biomedicines;2021-12-28

5. Genetic risk factors in the development of idiosyncratic drug-induced liver injury;Expert Opinion on Drug Metabolism & Toxicology;2020-12-14